Deardorf Caren
SEC insider (Form 3/4/5 filer). CIK 0001871152. Director at Crinetics Pharmaceuticals, Inc. (CRNX). 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in SAN DIEGO, CA.
Companies Deardorf Caren has filed insider reports for
- Crinetics Pharmaceuticals, Inc. (CRNX): Director
Deardorf Caren
CIK: 0001871152
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRNX
Crinetics Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect16.3K shares at avg. $85.00$1.4M - Sep 1, 2026CRNX
Crinetics Pharmaceuticals, Inc.
DispositionDirect5.9K shares at avg. $85.00$504K - Jun 18, 2026CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect5.9K shares- - Jun 11, 2025CRNX
Crinetics Pharmaceuticals, Inc.
AwardDirect6.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 16,300 | $85.00 | $1,385,500 | Direct |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Disposition | 5,925 | $85.00 | $503,625 | Direct |
| Jun 18, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 5,925 | - | $0 | Direct |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | Award | 6,900 | - | - | Direct |
1-4 of 4 transactions